UK MHRA Finds Labs Releasing Unreliable Data Due To Pressure From Pharma
Executive Summary
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.